$VATE
INNOVATE Corp. Stock $vate

$vate Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000100683722000015 Filed on March 09, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$394.8M	$1.205B	$178.0M
YoY Change	121.8%	68.11%	-163.87%
Cost Of Revenue	$333.1M	$1.022B	$140.8M
YoY Change	136.58%	73.58%	-137.01%
Gross Profit	$61.70M	$183.7M	$37.20M
YoY Change	65.86%	43.07%	-63.42%
Gross Profit Margin	15.63%	15.24%	20.9%
Selling, General & Admin	$47.40M	$168.3M	$36.30M
YoY Change	30.58%	15.67%	8.36%
% of Gross Profit	76.82%	91.62%	97.58%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$11.60M	$37.60M	$6.600M
YoY Change	75.76%	40.3%	-42.11%
% of Gross Profit	18.8%	20.47%	17.74%
Operating Expenses	$54.80M	$168.3M	$34.20M
YoY Change	60.23%	15.67%	-64.6%
Operating Profit	$6.900M	-$10.60M	$3.000M
YoY Change	130.0%	-62.54%	-41.18%
Interest Expense	-$10.50M	$59.10M	-$18.00M
YoY Change	-41.67%	-20.99%	9.09%
% of Operating Profit	-152.17%		-600.0%
Other Income/Expense, Net	-$100.0K	$4.300M	-$3.800M
YoY Change	-97.37%	-93.79%	-337.5%
Pretax Income	-$3.700M	-$80.70M	-$11.70M
YoY Change	-68.38%	72.81%	-79.22%
Income Tax	$1.800M	$5.600M	$3.300M
% Of Pretax Income
Net Earnings	-$4.700M	-$227.5M	-$4.700M
YoY Change	0.0%	147.28%	-85.03%
Net Earnings / Revenue	-1.19%	-18.88%	-2.64%
Basic Earnings Per Share		-$2.98
Diluted Earnings Per Share	-$60.72K	-$2.98	-$76.92K
COMMON SHARES
Basic Shares Outstanding	77.77M shares	77.10M shares	47.35M shares
Diluted Shares Outstanding		77.10M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$45.50M	$45.50M	$43.80M
YoY Change	3.88%	3.88%	-99.04%
Cash & Equivalents	$45.50M	$45.50M	$43.80M
Short-Term Investments
Other Short-Term Assets	$10.90M	$14.40M	$8.700M
YoY Change	25.29%	-99.76%	-99.09%
Inventory	$17.00M	$17.00M	$9.900M
Prepaid Expenses
Receivables	$247.1M	$128.3M	$134.7M
Other Receivables	$237.4M	$237.4M	$127.5M
Total Short-Term Assets	$442.6M	$442.6M	$6.227B
YoY Change	-92.89%	-92.89%	7.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$239.5M	$239.5M	$112.8M
YoY Change	112.32%	56.95%	-49.58%
Goodwill	$127.4M		$111.0M
YoY Change	14.77%		0.54%
Intangibles	$208.4M		$172.1M
YoY Change	21.09%		-18.28%
Long-Term Investments	$44.20M	$56.00M	$43.60M
YoY Change	1.38%	1.08%	-35.98%
Other Assets	$73.30M	$6.700M	$42.20M
YoY Change	73.7%	24.07%	-76.74%
Total Long-Term Assets	$638.0M	$638.0M	$496.5M
YoY Change	28.5%	28.5%	-58.18%
TOTAL ASSETS
Total Short-Term Assets	$442.6M	$442.6M	$6.227B
Total Long-Term Assets	$638.0M	$638.0M	$496.5M
Total Assets	$1.081B	$1.081B	$6.724B
YoY Change	-83.93%	-83.93%	-3.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$179.2M	$179.2M	$69.70M
YoY Change	157.1%	157.1%	1.6%
Accrued Expenses	$93.40M	$108.5M	$77.10M
YoY Change	21.14%	23.72%	-35.8%
Deferred Revenue	$79.10M		$33.20M
YoY Change	138.25%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$69.50M	$69.50M	$433.6M
YoY Change	-83.97%	-83.97%
Total Short-Term Liabilities	$439.5M	$439.5M	$5.933B
YoY Change	-92.59%	-92.59%	6.9%
LONG-TERM LIABILITIES
Long-Term Debt	$556.8M	$556.8M	$127.9M
YoY Change	335.34%	335.34%	-82.33%
Other Long-Term Liabilities	$63.30M	$63.30M	$39.80M
YoY Change	59.05%	59.05%	-71.05%
Total Long-Term Liabilities	$63.30M	$620.1M	$39.80M
YoY Change	59.05%	269.77%	-71.05%
TOTAL LIABILITIES
Total Short-Term Liabilities	$439.5M	$439.5M	$5.933B
Total Long-Term Liabilities	$63.30M	$620.1M	$39.80M
Total Liabilities	$1.069B	$1.146B	$6.108B
YoY Change	-82.5%	-81.38%	-5.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$416.2M		-$188.7M
YoY Change	120.56%		95.14%
Common Stock	$330.7M		$355.8M
YoY Change	-7.05%		26.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$5.200M		$4.200M
YoY Change	23.81%		27.27%
Treasury Stock Shares	1.389M shares		1.110M shares
Shareholders Equity	-$84.30M	-$65.50M	$559.8M
YoY Change
Total Liabilities & Shareholders Equity	$1.081B	$1.081B	$6.724B
YoY Change	-83.93%	-83.93%	-3.37%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$4.700M	-$227.5M	-$4.700M
YoY Change	0.0%	147.28%	-85.03%
Depreciation, Depletion And Amortization	$11.60M	$37.60M	$6.600M
YoY Change	75.76%	40.3%	-42.11%
Cash From Operating Activities	$41.60M	$27.00M	-$95.90M
YoY Change	-143.38%	-34.31%	-739.33%
INVESTING ACTIVITIES
Capital Expenditures	-$9.100M	$24.10M	-$3.200M
YoY Change	184.37%	35.39%	-122.86%
Acquisitions
YoY Change
Other Investing Activities	$800.0K	-$1.000M	$94.90M
YoY Change	-99.16%	-80.0%	-296.89%
Cash From Investing Activities	-$8.300M	-$223.2M	$91.70M
YoY Change	-109.05%	-237.69%	-247.43%
FINANCING ACTIVITIES
Cash Dividend Paid		$2.900M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$458.1M
YoY Change		151.84%
Cash From Financing Activities	-50.30M	$4.300M	19.30M
YoY Change	-360.62%	-102.1%	114.44%
NET CHANGE
Cash From Operating Activities	41.60M	$27.00M	-95.90M
Cash From Investing Activities	-8.300M	-$223.2M	91.70M
Cash From Financing Activities	-50.30M	$4.300M	19.30M
Net Change In Cash	-17.00M	$2.200M	15.10M
YoY Change	-212.58%	-89.32%	-139.53%
FREE CASH FLOW
Cash From Operating Activities	$41.60M	$27.00M	-$95.90M
Capital Expenditures	-$9.100M	$24.10M	-$3.200M
Free Cash Flow	$50.70M	$2.900M	-$92.70M
YoY Change	-154.69%	-87.55%	-9370.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001006837
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#DebtAndCapitalLeaseObligations
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#DebtAndCapitalLeaseObligations
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021	hchc	Preferred Stock Trading Period To Calculate Volume Weighted Average Price PreferredStockTradingPeriodToCalculateVolumeWeightedAveragePrice	P20D
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-35210
CY2021	dei	Entity Registrant Name EntityRegistrantName	INNOVATE CORP.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	54-1708481
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	295 Madison Avenue
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	12th Floor
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10017
CY2021	dei	City Area Code CityAreaCode	212
CY2021	dei	Local Phone Number LocalPhoneNumber	235-2690
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	193700000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	77836748	shares
CY2021	dei	Auditor Name AuditorName	BDO USA, LLP
CY2021	dei	Auditor Location AuditorLocation	New York, NY
CY2021	dei	Auditor Firm AuditorFirmId	243
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1205200000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	716900000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1021500000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	588500000	USD
CY2021	us-gaap	Gross Profit GrossProfit	183700000	USD
CY2020	us-gaap	Gross Profit GrossProfit	128400000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	168300000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	145500000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25400000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	17700000	USD
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-600000	USD
CY2020	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	6500000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-10600000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-28300000	USD
CY2021	us-gaap	Interest Expense InterestExpense	59100000	USD
CY2020	us-gaap	Interest Expense InterestExpense	74800000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-12500000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9400000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2800000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3400000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4300000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	69200000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-80700000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-46700000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5600000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7000000.0	USD
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-86300000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-53700000	USD
CY2020	hchc	Disposal Group Including Discontinued Operation Gain Loss On Sale Of Subsidiary DisposalGroupIncludingDiscontinuedOperationGainLossOnSaleOfSubsidiary	-44100000	USD
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-149900000	USD
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-48400000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-236200000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-102100000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8700000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-10100000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-227500000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-92000000.0	USD
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2200000	USD
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	3600000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-229700000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-95600000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.05
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.25
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.05
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.25
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-1.93
CY2020	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.63
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-1.93
CY2020	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.63
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.98
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.88
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.98
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.88
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77100000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50300000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77100000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50300000	shares
CY2021	us-gaap	Profit Loss ProfitLoss	-236200000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-102100000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2100000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	7900000	USD
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-57700000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	191600000	USD
CY2021	hchc	Other Comprehensive Income Loss Disposal Of Subsidiary Net Of Tax OtherComprehensiveIncomeLossDisposalOfSubsidiaryNetOfTax	-334000000.0	USD
CY2020	hchc	Other Comprehensive Income Loss Disposal Of Subsidiary Net Of Tax OtherComprehensiveIncomeLossDisposalOfSubsidiaryNetOfTax	30300000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-389600000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	229800000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-625800000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	127700000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	7800000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	8200000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-633600000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	119500000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45500000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43800000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	247100000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	134700000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	118600000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	86600000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	17000000.0	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	9900000	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	2000000.0	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1500000	USD
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	1500000	USD
CY2020Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	5942100000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	10900000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	8700000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	442600000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	6227300000	USD
CY2021Q4	us-gaap	Investments Investments	56000000.0	USD
CY2020Q4	us-gaap	Investments Investments	55400000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3000000.0	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3000000.0	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	169900000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	112800000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	127400000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	111000000.0	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	208400000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	172100000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	73300000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	42200000	USD
CY2021Q4	us-gaap	Assets Assets	1080600000	USD
CY2020Q4	us-gaap	Assets Assets	6723800000	USD
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	179200000	USD
CY2020Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	69700000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	93400000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	77100000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	69500000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	433600000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	79100000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	33200000	USD
CY2021Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	0	USD
CY2020Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	5306700000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	18300000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	12900000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	439500000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5933200000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	9100000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	7000000.0	USD
CY2021Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	556800000	USD
CY2020Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	127900000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	63300000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	39800000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	1068700000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	6107900000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	76726835	shares
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	18800000	USD
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Carrying Amount RedeemableNoncontrollingInterestEquityPreferredCarryingAmount	10400000	USD
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	49300000	USD
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	5300000	USD
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	68100000	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	15700000	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	100000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	100000	USD
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	160000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	160000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79225964	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	77836586	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	77836748	shares
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	330600000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	355700000	USD
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1389216	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1109751	shares
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	5200000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	4200000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-416200000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-188700000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	6400000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	396900000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-84300000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	559800000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	28100000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	40400000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-56200000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	600200000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1080600000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6723800000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	443600000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6300000	USD
CY2020	hchc	Fair Value Adjustment Of Redeemable Preferred Stock FairValueAdjustmentOfRedeemablePreferredStock	1300000	USD
CY2020	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	2000000.0	USD
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	900000	USD
CY2020	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	800000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	200000	USD
CY2020	hchc	Rights Offering RightsOffering	34500000	USD
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	27000000.0	USD
CY2020	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	50300000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	2100000	USD
CY2020	hchc	Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Temporary Equity NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingTemporaryEquity	-97400000	USD
CY2020	hchc	Other Comprehensive Income Loss Including Portion Attributableto Noncontrolling Interestand Redeemable Noncontrolling Interest OtherComprehensiveIncomeLossIncludingPortionAttributabletoNoncontrollingInterestandRedeemableNoncontrollingInterest	237200000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	600200000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2400000	USD
CY2021	hchc	Fair Value Adjustment Of Redeemable Preferred Stock FairValueAdjustmentOfRedeemablePreferredStock	-200000	USD
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1000000.0	USD
CY2021	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	2200000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	200000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	300000	USD
CY2021	us-gaap	Minority Interest Period Increase Decrease MinorityInterestPeriodIncreaseDecrease	34900000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-1700000	USD
CY2021	hchc	Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Temporary Equity NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingTemporaryEquity	-229500000	USD
CY2021	hchc	Other Comprehensive Income Loss Including Portion Attributableto Noncontrolling Interestand Redeemable Noncontrolling Interest OtherComprehensiveIncomeLossIncludingPortionAttributabletoNoncontrollingInterestandRedeemableNoncontrollingInterest	-389600000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-56200000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-236200000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-102100000	USD
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-149900000	USD
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-48400000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-86300000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-53700000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2400000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	2900000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	37600000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	26800000	USD
CY2021	hchc	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts	10500000	USD
CY2020	hchc	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts	15100000	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-100000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-12500000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9400000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2800000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3400000	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2800000	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	13700000	USD
CY2021	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0	USD
CY2020	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	72500000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2000000.0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4700000	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	4200000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	10300000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	38300000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-92900000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	19100000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	36100000	USD
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	300000	USD
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-4800000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-10600000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-9900000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	57900000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5800000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	8500000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-4700000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	7200000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-17500000	USD
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-2200000	USD
CY2020	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-17000000.0	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-10900000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-23300000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-6500000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-55200000	USD
CY2021	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	33500000	USD
CY2020	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	96300000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27000000.0	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41100000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24100000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17800000	USD
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	13200000	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	41200000	USD
CY2021	hchc	Proceeds From Sale Of Investments ProceedsFromSaleOfInvestments	0	USD
CY2020	hchc	Proceeds From Sale Of Investments ProceedsFromSaleOfInvestments	600000	USD
CY2021	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2020	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	85500000	USD
CY2021	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	74000000.0	USD
CY2020	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	147400000	USD
CY2021	hchc	Extraordinary Dividend Received In Business Disposition ExtraordinaryDividendReceivedInBusinessDisposition	62500000	USD
CY2020	hchc	Extraordinary Dividend Received In Business Disposition ExtraordinaryDividendReceivedInBusinessDisposition	0	USD
CY2021	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	128500000	USD
CY2020	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1000000.0	USD
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-5000000.0	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1900000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	261900000	USD
CY2021	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-221300000	USD
CY2020	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-99800000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-223200000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	162100000	USD
CY2021	hchc	Proceeds Payments From Debt Obligations ProceedsPaymentsFromDebtObligations	487600000	USD
CY2020	hchc	Proceeds Payments From Debt Obligations ProceedsPaymentsFromDebtObligations	-4100000	USD
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	458100000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	181900000	USD
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	38000000.0	USD
CY2021	hchc	Proceeds From Issuance Of Preferred Stock Subsidiary ProceedsFromIssuanceOfPreferredStockSubsidiary	10500000	USD
CY2020	hchc	Proceeds From Issuance Of Preferred Stock Subsidiary ProceedsFromIssuanceOfPreferredStockSubsidiary	37200000	USD
CY2021	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	10400000	USD
CY2020	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	0	USD
CY2021	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-13500000	USD
CY2020	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-62900000	USD
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-4200000	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-8800000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	11900000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-182500000	USD
CY2021	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-7600000	USD
CY2020	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-22000000.0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4300000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-204500000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1300000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1100000	USD
CY2021	hchc	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Net Increase Decrease In Cash And Cash Equivalents Including Cash Classified Within Assets Held For Sale CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsNetIncreaseDecreaseInCashAndCashEquivalentsIncludingCashClassifiedWithinAssetsHeldForSale	-193200000	USD
CY2020	hchc	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Net Increase Decrease In Cash And Cash Equivalents Including Cash Classified Within Assets Held For Sale CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsNetIncreaseDecreaseInCashAndCashEquivalentsIncludingCashClassifiedWithinAssetsHeldForSale	-200000	USD
CY2021	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	-195400000	USD
CY2020	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	-20800000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2200000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	20600000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45300000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24700000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47500000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45300000	USD
CY2021	us-gaap	Nature Of Operations NatureOfOperations	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">1. Organization and Business </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">INNOVATE Corp. ("INNOVATE", formerly known as HC2 Holdings, Inc.) and, together with its consolidated subsidiaries, the "Company", "we" and "our") is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. We seek to grow these businesses so that they can generate long-term sustainable free cash flow and attractive returns in order to maximize value for all stakeholders. While the Company generally intends to acquire controlling equity interests in its operating subsidiaries, the Company may invest to a limited extent in a variety of debt instruments or noncontrolling equity interest positions. The Company’s shares of common stock trade on the NYSE under the symbol "VATE".</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company currently has three reportable segments, plus our Other segment, based on management’s organization of the enterprise: Infrastructure, Life Sciences, Spectrum, and Other which includes businesses that do not meet the separately reportable segment thresholds.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:107%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:107%;padding-left:29.25pt">Our Infrastructure segment is comprised of DBM Global Inc. ("DBMG") and its wholly-owned subsidiaries. DBMG is a fully integrated Industrial Construction, Structural Steel and Facility Maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services and also fabricates trusses and girders and specializes in the fabrication and erection of large-diameter water pipe and water storage tanks, as well as 3-D Building Information Modeling (“BIM”) and detailing. DBMG provides these services on commercial, industrial, and infrastructure construction projects such as high- and low-rise buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, metal processing, refineries, pulp and paper mills and power plants. Through GrayWolf, DBMG provides integrated solutions for digital engineering, modeling and detailing, construction, heavy equipment installation and facility services including maintenance, repair, and installation to a diverse range of end markets. Through Aitken Manufacturing, DBMG manufactures pollution control scrubbers, tunnel liners, pressure vessels, strainers, filters, separators and a variety of customized products. Through the recently acquired Banker Steel, DBMG provides full-service fabricated structural steel and erection services primarily for the East Coast and Southeast commercial and industrial construction market, in addition to full design-assist services. The Company maintains an approximately 91% controlling interest in DBMG.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%;padding-left:29.25pt">Our Life Sciences segment is comprised of Pansend Life Sciences, LLC ("Pansend"). Pansend maintains controlling interests of approximately 80% in Genovel Orthopedics, Inc. ("Genovel"), which seeks to develop products to treat early osteoarthritis of the knee and approximately 56% in R2 Technologies, Inc. ("R2"), which develops aesthetic and medical technologies for the skin. Pansend also invests in other early stage or developmental stage healthcare companies including an approximately 47% interest in MediBeacon Inc. ("MediBeacon"), and an approximately 26% interest in Triple Ring Technologies, Inc ("Triple Ring"). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.25pt">Our Spectrum segment is comprised of HC2 Broadcasting Holdings Inc. ("Broadcasting") and its subsidiaries. Broadcasting strategically acquires and operates over-the-air broadcasting stations across the United States. In addition, Broadcasting, through its wholly-owned subsidiary, HC2 Network Inc. ("Network"), operates Azteca America, a Spanish-language broadcast network offering high quality Hispanic content to a diverse demographic across the United States. The Company maintains a 98% controlling interest in Broadcasting and maintains a controlling interest of approximately 77%, inclusive of approximately 10% proxy and voting rights from minority holders of DTV America Corporation ("DTV").</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.25pt">Our Other segment represents all other businesses or investments that do not meet the definition of a segment individually or in the aggregate. Included in the Other segment is the former Marine Services segment, which includes its holding company, Global Marine Holdings, LLC ("GMH"), in which the Company maintains approximately 73% controlling interest. GMH results include the current and prior year equity investment in HMN Technologies Co., Ltd. (“HMN”), its 19% equity method investment, and the discontinued operations of Global Marine Systems Limited ("GMSL"). Also included in the Other segment is the discontinued operations of Beyond6, Inc. ("Beyond6"), Continental Insurance Group ("CIG") and PTGi International Carrier Services, Inc. and its subsidiaries ("ICS").</span></div>
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	100000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	600000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of net revenue and expenses during the reporting period. Actual results may differ from these estimates. Significant estimates include allowance for doubtful accounts receivable, the extent of progress towards completion on contracts, contract revenue and costs on long-term contracts, valuation of certain investments and the insurance reserves, market assumptions used in estimating the fair values of certain assets and liabilities, the calculation used in determining the fair value of INNOVATE’s stock options required by ASC 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> ("ASC 718"), income taxes and various other contingencies.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Estimates of fair value represent the Company’s best estimates developed with the assistance of independent appraisals or various valuation techniques and, where the foregoing have not yet been completed or are not available, industry data and trends and by reference to relevant market rates and transactions. The estimates and assumptions are inherently subject to significant uncertainties and contingencies beyond the </span></div>control of the Company. Accordingly, the Company cannot provide assurance that the estimates, assumptions, and values reflected in the valuations will be realized, and actual results could vary materially.
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk and of Significant Suppliers</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, and accounts receivable. The Company maintains all cash and cash equivalents at accredited financial institutions, in amounts that exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company holds $4.7 million and $8.5 million cash in foreign accounts as of December 31, 2021 and 2020, respectively. The Company attempts to minimize the risks related to cash and cash equivalents by investing in a range of financial instruments as defined by the Company. Concentrations of credit risk with respect to accounts receivable are limited by the large number of customers comprising the Company's customer base and their geographic and business dispersion. The Company performs ongoing credit evaluations of the customers' financial condition and generally does not require collateral to support customer receivables. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the year ended December 31, 2021, one customer exceeded 10% of the Company's revenue and accounted for approximately 13.9%. No customers accounted for more than 10% of accounts receivable. For the fiscal year ended December 31, 2020, no customer accounted for more than 10% of the Company's revenue and no customers accounted for more than 10% of accounts receivable.</span></div>For the year ended December 31, 2021, one supplier accounted for more than 10% of the Company's accounts payable for approximately 15.1%. For the fiscal year ended December 31, 2020, no suppliers accounted for more than 10% of the Company's accounts payable.
CY2021Q4	hchc	Cash And Cash Equivalents In Foreign Accounts CashAndCashEquivalentsInForeignAccounts	4700000	USD
CY2020Q4	hchc	Cash And Cash Equivalents In Foreign Accounts CashAndCashEquivalentsInForeignAccounts	8500000	USD
CY2021	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-700000	USD
CY2020	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-2800000	USD
CY2021	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	0	USD
CY2020	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	71200000	USD
CY2021	hchc	Other Income Expense Net OtherIncomeExpenseNet	5000000.0	USD
CY2020	hchc	Other Income Expense Net OtherIncomeExpenseNet	800000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4300000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	69200000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43800000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23300000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1500000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1400000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45300000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24700000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45500000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43800000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2000000.0	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1500000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47500000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45300000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	32600000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	65100000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5400000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	200000	USD
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	1400000	USD
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	4400000	USD
CY2021	hchc	Increase Decrease In Accounts Payable Investments IncreaseDecreaseInAccountsPayableInvestments	0	USD
CY2020	hchc	Increase Decrease In Accounts Payable Investments IncreaseDecreaseInAccountsPayableInvestments	17100000	USD
CY2021	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	40900000	USD
CY2020	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	0	USD
CY2021	hchc	Noncash Or Part Noncash Extinguishment Of Convertible Note In Exchange NoncashOrPartNoncashExtinguishmentOfConvertibleNoteInExchange	51800000	USD
CY2020	hchc	Noncash Or Part Noncash Extinguishment Of Convertible Note In Exchange NoncashOrPartNoncashExtinguishmentOfConvertibleNoteInExchange	0	USD
CY2021	us-gaap	Notes Issued1 NotesIssued1	51800000	USD
CY2020	us-gaap	Notes Issued1 NotesIssued1	0	USD
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	6300000	USD
CY2021Q4	hchc	Contract With Customer Asset Usual Maximum Percentage Of Payment Withheld ContractWithCustomerAssetUsualMaximumPercentageOfPaymentWithheld	0.10
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	0	USD
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Reclassification</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain previous year amounts have been reclassified to conform with current year presentations, as related to the reporting of new balance sheet line items:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The recast of Beyond6, ICS, and CIG's results to discontinued operations. Further, the reclassification of prior period assets and liabilities have been classified as held for sale. See Note 3. Discontinued Operations for further information;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">As a result of the sale of ICS, and in accordance with ASC 280, the Company no longer considers the results of operations and balance sheets of the retained ICS entities as a separate segment. Formerly the Telecommunications segment, these entities have been reclassified to the Other segment. See Note 17. Operating Segment and Related Information for further information;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">As a result of the sale of Beyond6, and in accordance with ASC 280, the Company no longer considers the results of operations and balance sheets of Beyond6 as a separate segment. Formerly the Clean Energy segment, this entity has been reclassified to the Other segment. See Note 17. Operating Segment and Related Information for further information;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">As a result of the sale of CIG, and in accordance with ASC 280, the Company no longer considers the results of operations and Balance Sheets of CIG as a separate segment. This entity has been reclassified to the Other segment. See Note 17. Operating Segment and Related Information for further information; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:14.85pt">The recast of prior year earnings per share as a result of the discontinued operations noted above. This includes presenting EPS for Net income (loss) from continuing operations, Net income (loss) from discontinuing operations, and Net income (loss). See Note 18. Basic and Diluted Income (Loss) Per Common Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for further details.</span></div>
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1205200000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	716900000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	236500000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	125800000	USD
CY2021Q4	hchc	Contract With Customer Asset Retainage Receivable Percent To Be Collected Beyond One Year ContractWithCustomerAssetRetainageReceivablePercentToBeCollectedBeyondOneYear	0.246
CY2020Q4	hchc	Contract With Customer Asset Retainage Receivable Percent To Be Collected Beyond One Year ContractWithCustomerAssetRetainageReceivablePercentToBeCollectedBeyondOneYear	0.010
CY2021Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	226800000	USD
CY2020Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	118600000	USD
CY2021Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	400000	USD
CY2020Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	300000	USD
CY2021Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	9900000	USD
CY2020Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	7500000	USD
CY2021Q4	us-gaap	Other Receivables OtherReceivables	10600000	USD
CY2020Q4	us-gaap	Other Receivables OtherReceivables	8900000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	600000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	600000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	247100000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	134700000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	265000000.0	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	186300000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	95100000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	73500000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	169900000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	112800000	USD
CY2021	us-gaap	Depreciation Depreciation	25000000	USD
CY2020	us-gaap	Depreciation Depreciation	20800000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	200000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	900000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	111000000.0	USD
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	16700000	USD
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-300000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	127400000	USD
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	106500000	USD
CY2020Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	113000000.0	USD
CY2021Q4	hchc	Fcc License Renewal Weighted Average Period Until Next Renewal FCCLicenseRenewalWeightedAveragePeriodUntilNextRenewal	P3Y
CY2020Q4	hchc	Fcc License Renewal Weighted Average Period Until Next Renewal FCCLicenseRenewalWeightedAveragePeriodUntilNextRenewal	P2Y4M24D
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	134200000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	32300000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	101900000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	80100000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	21000000.0	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	59100000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12600000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6000000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	17200000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	11400000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	8000000.0	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	7300000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	6800000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	51200000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	101900000	USD
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	630800000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	576600000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	4500000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	15100000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	69500000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	433600000	USD
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	556800000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	127900000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	100000	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	115700000	USD
CY2021Q4	hchc	Long Term Debt And Lease Obligations Maturities Repayments Of Principal In Year One LongTermDebtAndLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearOne	115800000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	0	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	56400000	USD
CY2021Q4	hchc	Long Term Debt And Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	56400000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	0	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	107500000	USD
CY2021Q4	hchc	Long Term Debt And Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	107500000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	41300000	USD
CY2021Q4	hchc	Long Term Debt And Lease Obligations Maturities Repayments Of Principal In Year Four LongTermDebtAndLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	41300000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	0	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	487300000	USD
CY2021Q4	hchc	Long Term Debt And Lease Obligations Maturities Repayments Of Principal In Year Five LongTermDebtAndLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive	487300000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0	USD
CY2021Q4	hchc	Long Term Debt And Lease Obligations Maturities Repayments Of Principal After Year Five LongTermDebtAndLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive	0	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	100000	USD
CY2021Q4	hchc	Debt Including Interest Payable DebtIncludingInterestPayable	808200000	USD
CY2021Q4	hchc	Long Term Debt And Lease Obligation Including Current Maturities And Interest LongTermDebtAndLeaseObligationIncludingCurrentMaturitiesAndInterest	808300000	USD
CY2021Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	0	USD
CY2021Q4	hchc	Long Term Debt Maturities Interest Included In Payments LongTermDebtMaturitiesInterestIncludedInPayments	177500000	USD
CY2021Q4	hchc	Long Term Debt And Lease Obligations Maturities Interest Included In Payments LongTermDebtAndLeaseObligationsMaturitiesInterestIncludedInPayments	177500000	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	100000	USD
CY2021Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	630700000	USD
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	630800000	USD
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	50000	shares
CY2019Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	176.4
CY2019Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	8800000	USD
CY2019Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2021Q4	hchc	Costs Incurred On Contracts In Progress CostsIncurredOnContractsInProgress	2161500000	USD
CY2020Q4	hchc	Costs Incurred On Contracts In Progress CostsIncurredOnContractsInProgress	752900000	USD
CY2021Q4	hchc	Estimated Earnings On Contracts EstimatedEarningsOnContracts	316400000	USD
CY2020Q4	hchc	Estimated Earnings On Contracts EstimatedEarningsOnContracts	139000000.0	USD
CY2021Q4	hchc	Cost Earned On Uncompleted Contracts Gross CostEarnedOnUncompletedContractsGross	2477900000	USD
CY2020Q4	hchc	Cost Earned On Uncompleted Contracts Gross CostEarnedOnUncompletedContractsGross	891900000	USD
CY2021Q4	hchc	Progress Billing On Contract ProgressBillingOnContract	2438400000	USD
CY2020Q4	hchc	Progress Billing On Contract ProgressBillingOnContract	838500000	USD
CY2021Q4	hchc	Cost Earned On Uncompleted Contracts Net CostEarnedOnUncompletedContractsNet	39500000	USD
CY2020Q4	hchc	Cost Earned On Uncompleted Contracts Net CostEarnedOnUncompletedContractsNet	53400000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	118600000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	86600000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	79100000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	33200000	USD
CY2021Q4	hchc	Contract With Customer Net Asset Liability ContractWithCustomerNetAssetLiability	39500000	USD
CY2020Q4	hchc	Contract With Customer Net Asset Liability ContractWithCustomerNetAssetLiability	53400000	USD
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	14300000	USD
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	8700000	USD
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1200000	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	0	USD
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1500000	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1200000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	17000000.0	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	9900000	USD
CY2021Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	11800000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	44200000	USD
CY2021Q4	us-gaap	Investments Investments	56000000.0	USD
CY2020Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	11800000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	43600000	USD
CY2020Q4	us-gaap	Investments Investments	55400000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	4500000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	15100000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2800000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3400000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	69600000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	39800000	USD
CY2021Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	3700000	USD
CY2020Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	2400000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	73300000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	42200000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	24500000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	27900000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	38900000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	34700000	USD
CY2021Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	29600000	USD
CY2020Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	13900000	USD
CY2021Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	400000	USD
CY2020Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	600000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	93400000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	77100000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	58500000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31600000	USD
CY2021Q4	hchc	Other Liabilities Noncurrent Other OtherLiabilitiesNoncurrentOther	4800000	USD
CY2020Q4	hchc	Other Liabilities Noncurrent Other OtherLiabilitiesNoncurrentOther	8200000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	63300000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	39800000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	69600000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	39800000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	200000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	900000	USD
CY2021Q4	hchc	Lease Right Of Use Asset LeaseRightOfUseAsset	69800000	USD
CY2020Q4	hchc	Lease Right Of Use Asset LeaseRightOfUseAsset	40700000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	15500000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11200000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	58500000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	31600000	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	100000	USD
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	800000	USD
CY2021Q4	hchc	Lease Liability LeaseLiability	74100000	USD
CY2020Q4	hchc	Lease Liability LeaseLiability	43600000	USD
CY2021	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	2100000	USD
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	19200000	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	18000000	USD
CY2021Q4	us-gaap	Short Term Lease Commitment Amount ShortTermLeaseCommitmentAmount	9900000	USD
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	800000	USD
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	900000	USD
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	USD
CY2020	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	100000	USD
CY2021	hchc	Finance Lease Cost FinanceLeaseCost	800000	USD
CY2020	hchc	Finance Lease Cost FinanceLeaseCost	1000000.0	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	21700000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	14000000.0	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	500000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	200000	USD
CY2021	us-gaap	Sublease Income SubleaseIncome	500000	USD
CY2020	us-gaap	Sublease Income SubleaseIncome	0	USD
CY2021	us-gaap	Lease Cost LeaseCost	22500000	USD
CY2020	us-gaap	Lease Cost LeaseCost	15200000	USD
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	0	USD
CY2020	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	100000	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	700000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	700000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	21900000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	13900000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	100000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	100000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	48300000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	15600000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y6M
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2020Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y1M6D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.054
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.063
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.042
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.090
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	18700000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	100000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	16400000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	0	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	11600000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	0	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	8300000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5500000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	0	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	30700000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	91200000	USD
CY2021Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	100000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	17200000	USD
CY2021Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	0	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	74000000.0	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	100000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	100000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-10600000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1800000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1500000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1800000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	9500000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3700000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	400000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	800000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3100000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	200000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	100000	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	900000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	3400000	USD
CY2021	hchc	Deferred Income Tax Expense Benefits DeferredIncomeTaxExpenseBenefits	1900000	USD
CY2020	hchc	Deferred Income Tax Expense Benefits DeferredIncomeTaxExpenseBenefits	6600000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5600000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7000000.0	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-89700000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-125000000.0	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	9000000.0	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	78300000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-80700000	USD
CY2020	hchc	Income Tax Reconciliation Permanent Differences IncomeTaxReconciliationPermanentDifferences	200000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-46700000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-17000000.0	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-9800000	USD
CY2021	hchc	Income Tax Reconciliation Permanent Differences IncomeTaxReconciliationPermanentDifferences	400000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1600000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-6900000	USD
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	400000	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	200000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	400000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	1200000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-600000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	24300000	USD
CY2021	hchc	Income Tax Reconciliation Transaction Costs IncomeTaxReconciliationTransactionCosts	500000	USD
CY2020	hchc	Income Tax Reconciliation Transaction Costs IncomeTaxReconciliationTransactionCosts	500000	USD
CY2020	hchc	Effective Income Tax Rate Reconciliation Withholding Tax Expense EffectiveIncomeTaxRateReconciliationWithholdingTaxExpense	7300000	USD
CY2021	hchc	Effective Income Tax Rate Reconciliation Return To Provision Amount EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount	3300000	USD
CY2020	hchc	Effective Income Tax Rate Reconciliation Return To Provision Amount EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount	5600000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	20200000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-3000000.0	USD
CY2021	hchc	Effective Income Tax Rate Reconciliation Transition To The Coronavirus Aid Relief And Economic Security Act EffectiveIncomeTaxRateReconciliationTransitionToTheCoronavirusAidReliefAndEconomicSecurityAct	0	USD
CY2020	hchc	Effective Income Tax Rate Reconciliation Transition To The Coronavirus Aid Relief And Economic Security Act EffectiveIncomeTaxRateReconciliationTransitionToTheCoronavirusAidReliefAndEconomicSecurityAct	-10900000	USD
CY2021	hchc	Effective Income Tax Rate Reconciliation Withholding Tax Expense EffectiveIncomeTaxRateReconciliationWithholdingTaxExpense	0	USD
CY2021	us-gaap	Income Tax Reconciliation Disposition Of Business IncomeTaxReconciliationDispositionOfBusiness	0	USD
CY2020	us-gaap	Income Tax Reconciliation Disposition Of Business IncomeTaxReconciliationDispositionOfBusiness	-5800000	USD
CY2021	hchc	Effective Income Tax Rate Reconciliation Outside Basis Difference EffectiveIncomeTaxRateReconciliationOutsideBasisDifference	900000	USD
CY2020	hchc	Effective Income Tax Rate Reconciliation Outside Basis Difference EffectiveIncomeTaxRateReconciliationOutsideBasisDifference	-900000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	0	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	2200000	USD
CY2021	hchc	Effective Income Tax Rate Reconciliation Aoci Recycling EffectiveIncomeTaxRateReconciliationAOCIRecycling	0	USD
CY2020	hchc	Effective Income Tax Rate Reconciliation Aoci Recycling EffectiveIncomeTaxRateReconciliationAOCIRecycling	2100000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	1600000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	1300000	USD
CY2021	us-gaap	Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	1100000	USD
CY2020	us-gaap	Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	600000	USD
CY2021	hchc	Effective Income Tax Rate Reconciliation Derivative EffectiveIncomeTaxRateReconciliationDerivative	-1800000	USD
CY2020	hchc	Effective Income Tax Rate Reconciliation Derivative EffectiveIncomeTaxRateReconciliationDerivative	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5600000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7000000.0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5600000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7000000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	63800000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	77000000.0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	700000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	800000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	6700000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	6600000	USD
CY2021Q4	hchc	Deferred Tax Assets Interest Limitation Carryforward DeferredTaxAssetsInterestLimitationCarryforward	58100000	USD
CY2020Q4	hchc	Deferred Tax Assets Interest Limitation Carryforward DeferredTaxAssetsInterestLimitationCarryforward	58600000	USD
CY2021Q4	hchc	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	20900000	USD
CY2020Q4	hchc	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	13000000.0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	13400000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	20500000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	163600000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	176500000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	102800000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	115500000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	60800000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	61000000.0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	14100000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	22100000	USD
CY2021Q4	hchc	Deferred Tax Liabilities Operating Lease Right Of Use Asset DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset	19800000	USD
CY2020Q4	hchc	Deferred Tax Liabilities Operating Lease Right Of Use Asset DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset	12100000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	26100000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	22200000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	6900000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	8600000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	66900000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	65000000.0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	6100000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	4000000.0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	95700000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	58100000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	106400000	USD
CY2014Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	46100000	USD
CY2014Q4	hchc	Operating Loss Carryforward Annual Limitationon Use OperatingLossCarryforwardAnnualLimitationonUse	2300000	USD
CY2015Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	8500000	shares
CY2015Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	31700000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-58700000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	22900000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	5300000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	22900000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	17600000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	22900000	USD
CY2021Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	347100000	USD
CY2021Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	29800000	USD
CY2021Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	1400000	USD
CY2021Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	0	USD
CY2021Q4	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	0	USD
CY2021Q4	us-gaap	Purchase Obligation Due After Fifth Year PurchaseObligationDueAfterFifthYear	0	USD
CY2021Q4	us-gaap	Purchase Obligation PurchaseObligation	378300000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	143096	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.47
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y3M18D
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0024
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.6223
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2400000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3000000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2200000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	4800000	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	143096	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7067592	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.52
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.62
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	142503	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	5.45
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	2328327	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	9.18
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4739858	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.13
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	23999	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	5.31
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4715859	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.13
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4714509	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.13
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	200000	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y7M6D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	200000	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y7M6D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P0Y2M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1350	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.62
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	100000	USD
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	160000000	shares
CY2020Q4	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	59600000	USD
CY2020Q3	hchc	Proceeds From Rights Offering ProceedsFromRightsOffering	61500000	USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021Q4	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	300000	USD
CY2020Q4	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	800000	USD
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Preferred Fair Value RedeemableNoncontrollingInterestEquityPreferredFairValue	18800000	USD
CY2021Q3	hchc	Rights To Common Stock Holders Threshold Period RightsToCommonStockHoldersThresholdPeriod	P10D
CY2021Q3	hchc	Proceed From Exchange For Accrued And Unpaid Dividend ProceedFromExchangeForAccruedAndUnpaidDividend	300000	USD
CY2021	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.0750
CY2021	hchc	Preferred Stock Accreting Dividends Accruing Rate PreferredStockAccretingDividendsAccruingRate	0.0400
CY2021	hchc	Preferred Stock Accreting Dividends Accruing Rate Required Threshold PreferredStockAccretingDividendsAccruingRateRequiredThreshold	0.0725
CY2021	hchc	Volume Weighted Average Price Threshold Percentage VolumeWeightedAveragePriceThresholdPercentage	1.50
CY2021	hchc	Volume Weighted Average Price Threshold Percentage VolumeWeightedAveragePriceThresholdPercentage	1.50
CY2021	hchc	Volume Weighted Average Price Threshold Percentage VolumeWeightedAveragePriceThresholdPercentage	1.50
CY2021	hchc	Preferred Stock Force Conversion Trading Period To Calculate Volume Weighted Average Price PreferredStockForceConversionTradingPeriodToCalculateVolumeWeightedAveragePrice	P30D
CY2021	hchc	Preferred Stock Consent Rights Percentage PreferredStockConsentRightsPercentage	0.75
CY2021Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	200000	USD
CY2021Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	100000	USD
CY2021Q3	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	300000	USD
CY2021Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	300000	USD
CY2020Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	200000	USD
CY2020Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	200000	USD
CY2020Q3	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	200000	USD
CY2020Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	200000	USD
CY2018Q3	hchc	Lessee Lease Term LesseeLeaseTerm	P75M
CY2021Q3	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.049
CY2021Q3	hchc	Threshold Period To Result In Acquiring Person ThresholdPeriodToResultInAcquiringPerson	10	day
CY2021	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	600000	USD
CY2021	hchc	Number Of Geographic Reportable Segments NumberOfGeographicReportableSegments	1	segment
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2021	us-gaap	Revenues Revenues	1205200000	USD
CY2020	us-gaap	Revenues Revenues	716900000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-10600000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-28300000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-10600000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-28300000	USD
CY2021	us-gaap	Interest Expense InterestExpense	59100000	USD
CY2020	us-gaap	Interest Expense InterestExpense	74800000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-12500000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9400000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2800000	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3400000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4300000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	69200000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-80700000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-46700000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5600000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7000000.0	USD
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-86300000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-53700000	USD
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-149900000	USD
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-48400000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-236200000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-102100000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8700000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-10100000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-227500000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-92000000.0	USD
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2200000	USD
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	3600000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-229700000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-95600000	USD
CY2021	hchc	Depreciation Depletion And Amortization Nonproduction Including Cost Of Revenue DepreciationDepletionAndAmortizationNonproductionIncludingCostOfRevenue	37600000	USD
CY2020	hchc	Depreciation Depletion And Amortization Nonproduction Including Cost Of Revenue DepreciationDepletionAndAmortizationNonproductionIncludingCostOfRevenue	26800000	USD
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	24100000	USD
CY2020	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	17800000	USD
CY2021Q4	us-gaap	Investments Investments	56000000.0	USD
CY2020Q4	us-gaap	Investments Investments	55400000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	44200000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	43600000	USD
CY2021Q4	us-gaap	Assets Assets	1080600000	USD
CY2020Q4	us-gaap	Assets Assets	6723800000	USD
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-86300000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-53700000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-7800000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	5900000	USD
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-78500000	USD
CY2020	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-59600000	USD
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	2200000	USD
CY2020	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	3600000	USD
CY2021	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-80700000	USD
CY2020	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-63200000	USD
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-149900000	USD
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-48400000	USD
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-900000	USD
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-16000000.0	USD
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-149000000.0	USD
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-32400000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-229700000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-95600000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77100000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50300000	shares
CY2021	hchc	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Restricted Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofRestrictedStock	0	shares
CY2020	hchc	Incremental Common Shares Attributableto Dilutive Effectof Conversionof Restricted Stock IncrementalCommonSharesAttributabletoDilutiveEffectofConversionofRestrictedStock	0	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	400000	shares
CY2021	hchc	Participating Securities Including Common Stock Shares ParticipatingSecuritiesIncludingCommonStockShares	77100000	shares
CY2020	hchc	Participating Securities Including Common Stock Shares ParticipatingSecuritiesIncludingCommonStockShares	50700000	shares
CY2021	hchc	Percentageof Loss Allocatedto Common Stock PercentageofLossAllocatedtoCommonStock	1.000
CY2020	hchc	Percentageof Loss Allocatedto Common Stock PercentageofLossAllocatedtoCommonStock	0.992
CY2021	hchc	Percentageof Loss Allocatedto Unvested Restricted Stock PercentageofLossAllocatedtoUnvestedRestrictedStock	0
CY2020	hchc	Percentageof Loss Allocatedto Unvested Restricted Stock PercentageofLossAllocatedtoUnvestedRestrictedStock	0
CY2021	hchc	Percentageof Loss Allocatedto Preferred Stock PercentageofLossAllocatedtoPreferredStock	0
CY2020	hchc	Percentageof Loss Allocatedto Preferred Stock PercentageofLossAllocatedtoPreferredStock	0.008
CY2021	us-gaap	Undistributed Earnings Loss From Continuing Operations Available To Common Shareholders Basic UndistributedEarningsLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-80700000	USD
CY2020	us-gaap	Undistributed Earnings Loss From Continuing Operations Available To Common Shareholders Basic UndistributedEarningsLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-62700000	USD
CY2021	hchc	Undistributed Earnings Loss From Discontinued Operations Available To Common Shareholders Basic And Diluted UndistributedEarningsLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasicAndDiluted	-149000000.0	USD
CY2020	hchc	Undistributed Earnings Loss From Discontinued Operations Available To Common Shareholders Basic And Diluted UndistributedEarningsLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasicAndDiluted	-32100000	USD
CY2021	hchc	Undistributed Earnings Loss Available To Common Shareholders Basic And Diluted UndistributedEarningsLossAvailableToCommonShareholdersBasicAndDiluted	-229700000	USD
CY2020	hchc	Undistributed Earnings Loss Available To Common Shareholders Basic And Diluted UndistributedEarningsLossAvailableToCommonShareholdersBasicAndDiluted	-94800000	USD
CY2021	hchc	Effect On Basic And Diluted Earnings Convertible Instruments EffectOnBasicAndDilutedEarningsConvertibleInstruments	0	USD
CY2020	hchc	Effect On Basic And Diluted Earnings Convertible Instruments EffectOnBasicAndDilutedEarningsConvertibleInstruments	0	USD
CY2021	us-gaap	Undistributed Earnings Loss From Continuing Operations Available To Common Shareholders Diluted UndistributedEarningsLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-80700000	USD
CY2020	us-gaap	Undistributed Earnings Loss From Continuing Operations Available To Common Shareholders Diluted UndistributedEarningsLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-62700000	USD
CY2021	us-gaap	Undistributed Earnings Loss From Discontinued Operations Available To Common Shareholders Diluted UndistributedEarningsLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	-149000000.0	USD
CY2020	us-gaap	Undistributed Earnings Loss From Discontinued Operations Available To Common Shareholders Diluted UndistributedEarningsLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	-32100000	USD
CY2021	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Diluted UndistributedEarningsLossAvailableToCommonShareholdersDiluted	-229700000	USD
CY2020	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Diluted UndistributedEarningsLossAvailableToCommonShareholdersDiluted	-94800000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77100000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50300000	shares
CY2021	hchc	Effecton Basic And Diluted Earnings Optionsand Restrictive Stock Units EffectonBasicAndDilutedEarningsOptionsandRestrictiveStockUnits	0	shares
CY2020	hchc	Effecton Basic And Diluted Earnings Optionsand Restrictive Stock Units EffectonBasicAndDilutedEarningsOptionsandRestrictiveStockUnits	0	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	77100000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50300000	shares
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.05
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.25
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.05
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.25
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-1.93
CY2020	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.63
CY2021	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-1.93
CY2020	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.63
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.98
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.88
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.98
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.88

Files In Submission

Name	View Source	Status
0001006837-22-000015-index-headers.html	Edgar Link	pending
0001006837-22-000015-index.html	Edgar Link	pending
0001006837-22-000015.txt	Edgar Link	pending
0001006837-22-000015-xbrl.zip	Edgar Link	pending
exhibit1033-q410xk2021.htm	Edgar Link	pending
exhibit1034-q410xk2021.htm	Edgar Link	pending
exhibit1035-q410xk2021.htm	Edgar Link	pending
exhibit1036-q410xk2021.htm	Edgar Link	pending
exhibit1037-q410xk2021.htm	Edgar Link	pending
exhibit1038-q410xk2021.htm	Edgar Link	pending
exhibit211-q410k2021.htm	Edgar Link	pending
exhibit231-10k2021.htm	Edgar Link	pending
exhibit311-q410k2021.htm	Edgar Link	pending
exhibit312-q410k2021.htm	Edgar Link	pending
exhibit321-q410k2021.htm	Edgar Link	pending
exhibit417-q410xk2021.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hchc-20211231.htm	Edgar Link	pending
hchc-20211231.xsd	Edgar Link	pending
hchc-20211231_cal.xml	Edgar Link	unprocessable
hchc-20211231_def.xml	Edgar Link	unprocessable
hchc-20211231_g1.jpg	Edgar Link	pending
hchc-20211231_htm.xml	Edgar Link	completed
hchc-20211231_lab.xml	Edgar Link	unprocessable
hchc-20211231_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VATE
INNOVATE Corp. Stock $vate

2021 Q4 Form 10-K Financial Statement

#000100683722000015 Filed on March 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VATE INNOVATE Corp. Stock $vate

2021 Q4 Form 10-K Financial Statement

#000100683722000015 Filed on March 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VATE
INNOVATE Corp. Stock $vate